AIP
DXCM icon

Almanack Investment Partners’s DexCom DXCM Stock Holding History

Almanack Investment Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-712
Closed -$57K – 440
2022
Q3 		$57K Buy
+712
New +$60.3K 0.01% 242
2020
Q3 		– Sell
-3,384
Closed -$343K – 372
2020
Q2 		$343K Buy
+3,384
New +$303K 0.06% 167

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Almanack Investment Partners's DXCM Position: Q4 2022 in Review

Almanack Investment Partners sold out of DexCom (DXCM) in Q4 2022, closing a stake of 712 shares — an estimated $57K sold.

Almanack Investment Partners first reported a position in DXCM in Q2 2020 and held it in 2 quarters. The position peaked at $343K in Q2 2020. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

  • Almanack Investment Partners reported no remaining DexCom position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 712 DexCom shares in Q4 2022, an estimated $57K.
  • Almanack Investment Partners first reported a position in DexCom in Q2 2020 and held it in 2 quarters.
  • Almanack Investment Partners's DexCom position peaked at $343K in Q2 2020.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.